One of Wall Street's most prominent billionaire money managers has been a persistent seller of the face of the artificial ...

Historically, top-performing companies continue to generate robust returns. Businesses that conduct stock splits generate ...

Krispy Kreme's global brand provides a cushion, but execution will ultimately determine whether it becomes a long-term success. This is a high-risk, but potentially high-reward turnaround story.

Full-year 2025 guidance: non-GAAP operating margin -- Expected between 23.5% and 24.5%, reflecting increases in sales and ...

Total production -- Reached a quarterly record of approximately 1.62 million BOEs per day, reflecting a 19% increase, or ...

Quantum Computing Investors Need to Wake Up! IonQ's $2.5 Billion Warning Can't Be Ignored Any Longer. So far, these ...

One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Net Income -- $7.6 million, down from $9.3 million. Net income attributable to Karat ( KRT +1.51%) was $7.3 million, or $0.36 ...

Earlier this year, Bill Ackman's fund took a large stake in a company that it views as a free cash flow machine with ...

If you are looking to expand your investments in AI but want to diversify your portfolio away from chip stocks, I think one ...

Sure, people are nervous and prices may fall further. All cryptocurrencies carry risk. But -- unlike many other ...

MPM BioImpact fully exited its position in Crinetics Pharmaceuticals during the third quarter, a move disclosed in the fund’s ...